300 related articles for article (PubMed ID: 30055137)
1. Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis.
Rahouma M; Harrison S; Kamel M; Nasar A; Lee B; Port J; Altorki N; Stiles B
Ann Thorac Surg; 2018 Nov; 106(5):1476-1483. PubMed ID: 30055137
[TBL] [Abstract][Full Text] [Related]
2. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
[TBL] [Abstract][Full Text] [Related]
3. Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer.
Javidfar J; Speicher PJ; Hartwig MG; D'Amico TA; Berry MF
Ann Thorac Surg; 2016 Mar; 101(3):1060-7. PubMed ID: 26576752
[TBL] [Abstract][Full Text] [Related]
4. Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.
Vlacich G; Samson PP; Perkins SM; Roach MC; Parikh PJ; Bradley JD; Lockhart AC; Puri V; Meyers BF; Kozower B; Robinson CG
Cancer Med; 2017 Dec; 6(12):2886-2896. PubMed ID: 29139215
[TBL] [Abstract][Full Text] [Related]
5. Sex Disparities After Induction Chemoradiotherapy and Esophagogastrectomy for Esophageal Cancer.
Rowse PG; Jaroszewski DE; Thomas M; Harold K; Harmsen WS; Shen KR
Ann Thorac Surg; 2017 Oct; 104(4):1147-1152. PubMed ID: 28842111
[TBL] [Abstract][Full Text] [Related]
6. Survival After Esophagectomy: A Propensity-Matched Study of Different Surgical Approaches.
Weksler B; Sullivan JL
Ann Thorac Surg; 2017 Oct; 104(4):1138-1146. PubMed ID: 28760463
[TBL] [Abstract][Full Text] [Related]
7. Comparison Between Esophagectomy and Definitive Chemoradiotherapy in Patients With Esophageal Cancer.
Wang BY; Hung WH; Wu SC; Chen HC; Huang CL; Lin CH; Chen HS
Ann Thorac Surg; 2019 Apr; 107(4):1060-1067. PubMed ID: 30571951
[TBL] [Abstract][Full Text] [Related]
8. Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?
Markar S; Gronnier C; Duhamel A; Pasquer A; Théreaux J; du Rieu MC; Lefevre JH; Turner K; Luc G; Mariette C
J Clin Oncol; 2015 Nov; 33(33):3866-73. PubMed ID: 26195702
[TBL] [Abstract][Full Text] [Related]
9. Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer.
Speicher PJ; Englum BR; Ganapathi AM; Wang X; Hartwig MG; D'Amico TA; Berry MF
Ann Surg; 2017 Apr; 265(4):743-749. PubMed ID: 28266965
[TBL] [Abstract][Full Text] [Related]
10. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma.
Rice TW; Adelstein DJ; Chidel MA; Rybicki LA; DeCamp MM; Murthy SC; Blackstone EH
J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1590-6. PubMed ID: 14666038
[TBL] [Abstract][Full Text] [Related]
11. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma.
Barbetta A; Schlottmann F; Nobel T; Sewell DB; Hsu M; Tan KS; Gerdes H; Shah P; Bains MS; Bott M; Isbell JM; Jones DR; Molena D
Ann Thorac Surg; 2018 Jul; 106(1):172-177. PubMed ID: 29627387
[TBL] [Abstract][Full Text] [Related]
13. Safety and benefit of curative surgical resection for esophageal squamous cell cancer associated with multiple primary cancers.
Otowa Y; Nakamura T; Takiguchi G; Yamamoto M; Kanaji S; Imanishi T; Oshikiri T; Suzuki S; Tanaka K; Kakeji Y
Eur J Surg Oncol; 2016 Mar; 42(3):407-11. PubMed ID: 26733367
[TBL] [Abstract][Full Text] [Related]
14. Trends in Treatment of T1N0 Esophageal Cancer.
Semenkovich TR; Hudson JL; Subramanian M; Mullady DK; Meyers BF; Puri V; Kozower BD
Ann Surg; 2019 Sep; 270(3):434-443. PubMed ID: 31274653
[TBL] [Abstract][Full Text] [Related]
15. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
[TBL] [Abstract][Full Text] [Related]
16. Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes.
Shao MS; Wong AT; Schwartz D; Weiner JP; Schreiber D
Ann Thorac Surg; 2016 Jun; 101(6):2148-54. PubMed ID: 27016842
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.
Saeki H; Tsutsumi S; Tajiri H; Yukaya T; Tsutsumi R; Nishimura S; Nakaji Y; Kudou K; Akiyama S; Kasagi Y; Nakanishi R; Nakashima Y; Sugiyama M; Ohgaki K; Sonoda H; Oki E; Maehara Y
Ann Surg; 2017 Mar; 265(3):527-533. PubMed ID: 28169928
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection.
Hsu PK; Huang CS; Wang BY; Wu YC; Chou TY; Hsu WH
Ann Thorac Surg; 2013 Sep; 96(3):995-1001. PubMed ID: 23866797
[TBL] [Abstract][Full Text] [Related]
19. Incidence and Risk Factors for Isolated Esophageal Cancer Recurrence to the Brain.
Nobel TB; Dave N; Eljalby M; Xing X; Barbetta A; Hsu M; Tan KS; Janjigian Y; Bains MS; Sihag S; Jones DR; Molena D
Ann Thorac Surg; 2020 Feb; 109(2):329-336. PubMed ID: 31614136
[TBL] [Abstract][Full Text] [Related]
20. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
